Acumen Pharmaceuticals Inc (ABOS)
3.09
-0.09
(-2.83%)
USD |
NASDAQ |
Apr 25, 10:53
Acumen Pharmaceuticals Price to Book Value: 0.6953 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 0.7156 |
| April 23, 2024 | 0.7111 |
| April 22, 2024 | 0.7044 |
| April 19, 2024 | 0.7089 |
| April 18, 2024 | 0.7111 |
| April 17, 2024 | 0.7809 |
| April 16, 2024 | 0.7876 |
| April 15, 2024 | 0.7944 |
| April 12, 2024 | 0.8417 |
| April 11, 2024 | 0.8754 |
| April 10, 2024 | 0.8349 |
| April 09, 2024 | 0.8642 |
| April 08, 2024 | 0.8754 |
| April 05, 2024 | 0.8664 |
| April 04, 2024 | 0.8642 |
| April 03, 2024 | 0.8799 |
| April 02, 2024 | 0.8529 |
| April 01, 2024 | 0.9024 |
| March 28, 2024 | 0.9114 |
| March 27, 2024 | 0.9227 |
| March 26, 2024 | 0.8439 |
| March 25, 2024 | 0.9564 |
| March 22, 2024 | 0.9677 |
| March 21, 2024 | 0.9744 |
| March 20, 2024 | 0.9339 |
| Date | Value |
|---|---|
| March 19, 2024 | 0.8677 |
| March 18, 2024 | 0.8633 |
| March 15, 2024 | 0.9067 |
| March 14, 2024 | 0.8872 |
| March 13, 2024 | 0.9436 |
| March 12, 2024 | 0.8937 |
| March 11, 2024 | 0.9284 |
| March 08, 2024 | 0.9479 |
| March 07, 2024 | 0.9479 |
| March 06, 2024 | 0.9653 |
| March 05, 2024 | 0.9436 |
| March 04, 2024 | 0.9718 |
| March 01, 2024 | 1.006 |
| February 29, 2024 | 0.9349 |
| February 28, 2024 | 0.9045 |
| February 27, 2024 | 0.8828 |
| February 26, 2024 | 0.7896 |
| February 23, 2024 | 0.7722 |
| February 22, 2024 | 0.7245 |
| February 21, 2024 | 0.7267 |
| February 20, 2024 | 0.7202 |
| February 16, 2024 | 0.7115 |
| February 15, 2024 | 0.6789 |
| February 14, 2024 | 0.6833 |
| February 13, 2024 | 0.6703 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3843
Minimum
Nov 09 2023
2.655
Maximum
Oct 05 2021
1.171
Average
1.060
Median
Price to Book Value Benchmarks
| Accuray Inc | 4.485 |
| Johnson & Johnson | 5.141 |
| Kezar Life Sciences Inc | 0.3000 |
| Akoya Biosciences Inc | 3.491 |
| NovaBay Pharmaceuticals Inc | 1.644 |
Price to Book Value Related Metrics
| Price | 3.09 |
| Earnings Yield | -35.28% |
| Market Cap | 185.65M |